On June 1, 2026, Florida Attorney General James Uthmeier filed a ten-count complaint against OpenAI and its Chief Executive Officer, Sam Altman, in what appears to be the first…
On June 1, 2026, Florida Attorney General James Uthmeier filed a ten-count complaint against OpenAI and its Chief Executive Officer, Sam Altman, in what appears to be the first state enforcement action of its kind targeting a major generative artificial intelligence developer. The complaint alleges that OpenAI marketed ChatGPT as a safe product to consumers while concealing material risks to usersΓÇöparticularly minorsΓÇöand that the company collected data from children without obtaining verifiable parental consent. The action marks a significant inflection point in how state regulators are approaching the rapidly expanding generative AI marketplace.
The complaint asserts claims under the Florida Deceptive and Unfair Trade Practices Act, alongside product liability and public nuisance theories. The Attorney General is seeking civil penalties of up to $10,000 per violation, together with injunctive relief and disgorgement of profits. The breadth of these requested remedies is notable: by coupling consumer protection statutes with traditional tort frameworks, the State is signaling that AI products may be regulated through multiple, overlapping legal regimes. For other state attorneys general considering similar action, Florida's filing provides a roadmap that combines familiar statutory tools with novel applications to AI-driven harms.
For clients building, integrating, or marketing AI-enabled products and services, the implications are substantial. Companies should reassess the accuracy of their public safety representations, including statements made in marketing materials, user-facing disclosures, and terms of service. Age-gating procedures and parental consent mechanisms warrant immediate scrutiny, particularly for any product reasonably accessible to minors. Data collection practices involving children should be audited against verifiable consent standards, and product warnings should be reviewed to ensure they meaningfully address foreseeable risks of use and misuse.
Beyond Florida, the action is likely to accelerate parallel investigations and enforcement initiatives in other jurisdictions. Companies should anticipate increased regulatory attention to safety claims, data handling involving minors, and the adequacy of guardrails built into generative AI systems. Proactive compliance reviews, internal documentation of safety testing, and coordinated messaging across legal, product, and marketing functions can meaningfully reduce exposure as the enforcement landscape continues to evolve.
This article is provided for general informational purposes only and does not constitute legal advice. Clients should consult counsel for guidance tailored to their specific circumstances.